0001506983 false 0001506983 2023-03-31 2023-03-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 31, 2023

 

GLUCOTRACK, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-41141   98-0668934
(State or Other Jurisdiction   (Commission   (IRS Employer
of Incorporation)   File Number)   Identification No.)

 

8 Ariel Sharon Street, P.O. Box 6037607, Or Yehuda, Israel   L3 7760049
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: 972 (8) 675-7878

 

N/A

(Former name or former address, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock   GCTK   Nasdaq Capital Market

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR § 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR § 240.12b-2).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 5.07 Submission of Matters to a Vote of Security Holders

 

On March 31, 2023, GlucoTrack, Inc. held its 2022 Annual Meeting of Shareholders. The results of the voting with respect to this Annual Meeting are as set forth below.

 

DIRECTORS INFORMATION
DIR # 

VOTES

FOR

   VOTES WITHHELD   BROKER NON-VOTE  

% VOTES

FOR

 
Dr. Robert Fischell   2,881,036.00    5,250,502.00    488,583.00    18.58 
Luis Malave   2,880,918.00    5,250,620.00    488,583.00    18.58 
Andrew Sycoff   2,945,847.00    5,185,691.00    488,583.00    19.00 
Shimon Rapps   2,882,073.00    5,249,465.00    488,583.00    18.59 
Allen Danzig   2,880,916.00    5,250,622.00    488,583.00    18.58 

 

PROPOSALS INFORMATION 
PROP # 

VOTES

FOR

   VOTES AGAINST   VOTES ABSTAIN   BROKER NON-VOTE   % VOTES FOR 
Ratify Auditor   8,612,584.00    7,481.00    56.00    0.00    55.55 
Nonbinding Say on Pay   2,844,095.00    5,205,181.00    82,262.00    488,583.00    18.34 

 

ITEM 9.01 Exhibit

 

Exhibit 104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: April 6, 2023  
   
  GLUCOTRACK, INC.
     
  By: /s/ Jolie Kahn               
  Name: Jolie Kahn
  Title: Chief Financial Officer

 

 

Integrity Applications (NASDAQ:IGAP)
Historical Stock Chart
From Dec 2024 to Jan 2025 Click Here for more Integrity Applications Charts.
Integrity Applications (NASDAQ:IGAP)
Historical Stock Chart
From Jan 2024 to Jan 2025 Click Here for more Integrity Applications Charts.